Skip to main content
The British Journal of General Practice logoLink to The British Journal of General Practice
. 1996 Jun;46(407):367–370.

Who needs antiplatelet therapy?

M Moher 1, T Lancaster 1
PMCID: PMC1239672  PMID: 8983259

Abstract

A series of overviews or meta-analyses of randomized clinical trials prepared by the Antiplatelet Trialists' Collaboration were published in the British Medical Journal in January 1994. They demonstrated that prolonged courses of medium-dose aspirin were very effective at preventing both fatal and non-fatal myocardial infarction and stroke in patients at high risk of occlusive vascular disease. The aim of this review is to provide the general practitioner with a practical guide to the use of aspirin in patients at high and low risk of occlusive vascular disease and to discuss appropriate dosages and contraindications to treatment in the light of all the recent evidence.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bamford J., Dennis M., Sandercock P., Burn J., Warlow C. The frequency, causes and timing of death within 30 days of a first stroke: the Oxfordshire Community Stroke Project. J Neurol Neurosurg Psychiatry. 1990 Oct;53(10):824–829. doi: 10.1136/jnnp.53.10.824. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Deeks J., Watt I., Freemantle N. Aspirin and acute myocardial infarction: clarifying the message. Br J Gen Pract. 1995 Aug;45(397):395–396. [PMC free article] [PubMed] [Google Scholar]
  3. Dennis M. S., Bamford J. M., Molyneux A. J., Warlow C. P. Rapid resolution of signs of primary intracerebral haemorrhage in computed tomograms of the brain. Br Med J (Clin Res Ed) 1987 Aug 8;295(6594):379–381. doi: 10.1136/bmj.295.6594.379. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Fahey T., Newton J. Conveying the benefits and risks of treatment. Br J Gen Pract. 1995 Jul;45(396):339–341. [PMC free article] [PubMed] [Google Scholar]
  5. Fry J. The natural history of angina in a general practice. J R Coll Gen Pract. 1976 Sep;26(170):643–646. [PMC free article] [PubMed] [Google Scholar]
  6. Juul-Möller S., Edvardsson N., Jahnmatz B., Rosén A., Sørensen S., Omblus R. Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. The Swedish Angina Pectoris Aspirin Trial (SAPAT) Group. Lancet. 1992 Dec 12;340(8833):1421–1425. doi: 10.1016/0140-6736(92)92619-q. [DOI] [PubMed] [Google Scholar]
  7. Kannel W. B., Feinleib M. Natural history of angina pectoris in the Framingham study. Prognosis and survival. Am J Cardiol. 1972 Feb;29(2):154–163. doi: 10.1016/0002-9149(72)90624-8. [DOI] [PubMed] [Google Scholar]
  8. Laupacis A., Sackett D. L., Roberts R. S. An assessment of clinically useful measures of the consequences of treatment. N Engl J Med. 1988 Jun 30;318(26):1728–1733. doi: 10.1056/NEJM198806303182605. [DOI] [PubMed] [Google Scholar]
  9. Petersen P., Boysen G., Godtfredsen J., Andersen E. D., Andersen B. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study. Lancet. 1989 Jan 28;1(8631):175–179. doi: 10.1016/s0140-6736(89)91200-2. [DOI] [PubMed] [Google Scholar]
  10. Roderick P. J., Wilkes H. C., Meade T. W. The gastrointestinal toxicity of aspirin: an overview of randomised controlled trials. Br J Clin Pharmacol. 1993 Mar;35(3):219–226. doi: 10.1111/j.1365-2125.1993.tb05689.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Shaper A. G., Pocock S. J., Walker M., Phillips A. N., Whitehead T. P., Macfarlane P. W. Risk factors for ischaemic heart disease: the prospective phase of the British Regional Heart Study. J Epidemiol Community Health. 1985 Sep;39(3):197–209. doi: 10.1136/jech.39.3.197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Sweeney K. G., Gray D. P., Steele R., Evans P. Use of warfarin in non-rheumatic atrial fibrillation: a commentary from general practice. Br J Gen Pract. 1995 Mar;45(392):153–158. [PMC free article] [PubMed] [Google Scholar]
  13. Wolf P. A., Abbott R. D., Kannel W. B. Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study. Arch Intern Med. 1987 Sep;147(9):1561–1564. [PubMed] [Google Scholar]

Articles from The British Journal of General Practice are provided here courtesy of Royal College of General Practitioners

RESOURCES